UniProt ID | LSR_HUMAN | |
---|---|---|
UniProt AC | Q86X29 | |
Protein Name | Lipolysis-stimulated lipoprotein receptor | |
Gene Name | LSR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 649 | |
Subcellular Localization |
Cell membrane Single-pass membrane protein . |
|
Protein Description | Probable role in the clearance of triglyceride-rich lipoprotein from blood. Binds chylomicrons, LDL and VLDL in presence of free fatty acids and allows their subsequent uptake in the cells (By similarity).. | |
Protein Sequence | MQQDGLGVGTRNGSGKGRSVHPSWPWCAPRPLRYFGRDARARRAQTAAMALLAGGLSRGLGSHPAAAGRDAVVFVWLLLSTWCTAPARAIQVTVSNPYHVVILFQPVTLPCTYQMTSTPTQPIVIWKYKSFCRDRIADAFSPASVDNQLNAQLAAGNPGYNPYVECQDSVRTVRVVATKQGNAVTLGDYYQGRRITITGNADLTFDQTAWGDSGVYYCSVVSAQDLQGNNEAYAELIVLGRTSGVAELLPGFQAGPIEDWLFVVVVCLAAFLIFLLLGICWCQCCPHTCCCYVRCPCCPDKCCCPEALYAAGKAATSGVPSIYAPSTYAHLSPAKTPPPPAMIPMGPAYNGYPGGYPGDVDRSSSAGGQGSYVPLLRDTDSSVASEVRSGYRIQASQQDDSMRVLYYMEKELANFDPSRPGPPSGRVERAMSEVTSLHEDDWRSRPSRGPALTPIRDEEWGGHSPRSPRGWDQEPAREQAGGGWRARRPRARSVDALDDLTPPSTAESGSRSPTSNGGRSRAYMPPRSRSRDDLYDQDDSRDFPRSRDPHYDDFRSRERPPADPRSHHHRTRDPRDNGSRSGDLPYDGRLLEEAVRKKGSEERRRPHKEEEEEAYYPPAPPPYSETDSQASRERRLKKNLALSRESLVV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | QDGLGVGTRNGSGKG CCCCCCCCCCCCCCC | 20.68 | 20068231 | |
14 | Phosphorylation | GVGTRNGSGKGRSVH CCCCCCCCCCCCCCC | 40.66 | 20068231 | |
23 | Phosphorylation | KGRSVHPSWPWCAPR CCCCCCCCCCCCCCC | 30.78 | 24719451 | |
46 | Phosphorylation | ARARRAQTAAMALLA HHHHHHHHHHHHHHH | 18.52 | 25884760 | |
57 | Phosphorylation | ALLAGGLSRGLGSHP HHHHHHHHHCCCCCH | 27.81 | 25884760 | |
116 | Phosphorylation | LPCTYQMTSTPTQPI ECCEEECCCCCCCCE | 17.58 | 29083192 | |
117 | Phosphorylation | PCTYQMTSTPTQPIV CCEEECCCCCCCCEE | 27.35 | 29083192 | |
118 | Phosphorylation | CTYQMTSTPTQPIVI CEEECCCCCCCCEEE | 22.61 | 29083192 | |
120 | Phosphorylation | YQMTSTPTQPIVIWK EECCCCCCCCEEEEE | 47.25 | 29083192 | |
131 | Ubiquitination | VIWKYKSFCRDRIAD EEEEEHHHHCHHHHH | 3.28 | 21890473 | |
141 | O-linked_Glycosylation | DRIADAFSPASVDNQ HHHHHCCCHHHHHHH | 22.68 | OGP | |
142 (in isoform 2) | Ubiquitination | - | 23.31 | 21890473 | |
144 | Phosphorylation | ADAFSPASVDNQLNA HHCCCHHHHHHHHHH | 33.13 | 26657352 | |
150 (in isoform 6) | Phosphorylation | - | 18.84 | 29514088 | |
153 (in isoform 6) | Phosphorylation | - | 3.07 | 29514088 | |
179 | Ubiquitination | TVRVVATKQGNAVTL EEEEEEECCCCEEEE | 46.61 | - | |
179 | Ubiquitination | TVRVVATKQGNAVTL EEEEEEECCCCEEEE | 46.61 | 21906983 | |
179 (in isoform 1) | Ubiquitination | - | 46.61 | 21890473 | |
179 (in isoform 3) | Ubiquitination | - | 46.61 | 21890473 | |
185 | O-linked_Glycosylation | TKQGNAVTLGDYYQG ECCCCEEEECCEECC | 23.71 | 171669 | |
185 | Phosphorylation | TKQGNAVTLGDYYQG ECCCCEEEECCEECC | 23.71 | 21082442 | |
189 | Phosphorylation | NAVTLGDYYQGRRIT CEEEECCEECCCEEE | 8.90 | - | |
190 | Phosphorylation | AVTLGDYYQGRRITI EEEECCEECCCEEEE | 14.83 | - | |
216 | Phosphorylation | AWGDSGVYYCSVVSA CCCCCCEEEEEEEEH | 11.41 | 32142685 | |
227 | Ubiquitination | VVSAQDLQGNNEAYA EEEHHHCCCCCHHEE | 61.94 | 23503661 | |
254 | Ubiquitination | ELLPGFQAGPIEDWL HHCCCCCCCCHHHHH | 24.38 | 21890473 | |
267 | Ubiquitination | WLFVVVVCLAAFLIF HHHHHHHHHHHHHHH | 1.13 | 23503661 | |
286 | Ubiquitination | ICWCQCCPHTCCCYV HHHHHHCCCCCEEEE | 33.19 | 23503661 | |
290 | Phosphorylation | QCCPHTCCCYVRCPC HHCCCCCEEEEECCC | 1.65 | - | |
293 | Ubiquitination | PHTCCCYVRCPCCPD CCCCEEEEECCCCCC | 2.95 | 29901268 | |
298 (in isoform 2) | Ubiquitination | - | 2.70 | - | |
302 | Ubiquitination | CPCCPDKCCCPEALY CCCCCCCCCCHHHHH | 3.63 | 23000965 | |
304 | Phosphorylation | CCPDKCCCPEALYAA CCCCCCCCHHHHHHH | 4.84 | - | |
307 | Phosphorylation | DKCCCPEALYAAGKA CCCCCHHHHHHHHHH | 7.33 | - | |
309 | Phosphorylation | CCCPEALYAAGKAAT CCCHHHHHHHHHHHH | 11.06 | 21945579 | |
313 | Phosphorylation | EALYAAGKAATSGVP HHHHHHHHHHHCCCC | 30.07 | - | |
313 | Ubiquitination | EALYAAGKAATSGVP HHHHHHHHHHHCCCC | 30.07 | - | |
316 | O-linked_Glycosylation | YAAGKAATSGVPSIY HHHHHHHHCCCCCEE | 30.76 | 55821201 | |
316 | Phosphorylation | YAAGKAATSGVPSIY HHHHHHHHCCCCCEE | 30.76 | 21945579 | |
316 | Ubiquitination | YAAGKAATSGVPSIY HHHHHHHHCCCCCEE | 30.76 | 23503661 | |
317 | O-linked_Glycosylation | AAGKAATSGVPSIYA HHHHHHHCCCCCEEC | 32.82 | 55821207 | |
317 | Phosphorylation | AAGKAATSGVPSIYA HHHHHHHCCCCCEEC | 32.82 | 21945579 | |
321 | Phosphorylation | AATSGVPSIYAPSTY HHHCCCCCEECCCCC | 26.31 | 21945579 | |
323 | Phosphorylation | TSGVPSIYAPSTYAH HCCCCCEECCCCCCC | 19.46 | 21945579 | |
326 | O-linked_Glycosylation | VPSIYAPSTYAHLSP CCCEECCCCCCCCCC | 26.36 | 19901323 | |
326 | Phosphorylation | VPSIYAPSTYAHLSP CCCEECCCCCCCCCC | 26.36 | 21945579 | |
327 | O-linked_Glycosylation | PSIYAPSTYAHLSPA CCEECCCCCCCCCCC | 24.54 | 24870719 | |
327 | Phosphorylation | PSIYAPSTYAHLSPA CCEECCCCCCCCCCC | 24.54 | 21945579 | |
328 | Phosphorylation | SIYAPSTYAHLSPAK CEECCCCCCCCCCCC | 9.07 | 21945579 | |
332 | O-linked_Glycosylation | PSTYAHLSPAKTPPP CCCCCCCCCCCCCCC | 16.97 | 14643711 | |
332 | Phosphorylation | PSTYAHLSPAKTPPP CCCCCCCCCCCCCCC | 16.97 | 21945579 | |
335 | Ubiquitination | YAHLSPAKTPPPPAM CCCCCCCCCCCCCCC | 66.02 | 23503661 | |
336 | Phosphorylation | AHLSPAKTPPPPAMI CCCCCCCCCCCCCCC | 43.04 | 21945579 | |
341 | Ubiquitination | AKTPPPPAMIPMGPA CCCCCCCCCCCCCCC | 17.82 | 23000965 | |
342 | Ubiquitination | KTPPPPAMIPMGPAY CCCCCCCCCCCCCCC | 4.33 | 23000965 | |
347 | Phosphorylation | PAMIPMGPAYNGYPG CCCCCCCCCCCCCCC | 25.89 | 32142685 | |
349 | Phosphorylation | MIPMGPAYNGYPGGY CCCCCCCCCCCCCCC | 16.56 | 21945579 | |
352 | Phosphorylation | MGPAYNGYPGGYPGD CCCCCCCCCCCCCCC | 8.61 | 21945579 | |
352 (in isoform 2) | Ubiquitination | - | 8.61 | 21890473 | |
353 | Phosphorylation | GPAYNGYPGGYPGDV CCCCCCCCCCCCCCC | 31.00 | - | |
356 | Phosphorylation | YNGYPGGYPGDVDRS CCCCCCCCCCCCCCC | 15.23 | 21945579 | |
361 | Ubiquitination | GGYPGDVDRSSSAGG CCCCCCCCCCCCCCC | 49.86 | 23000965 | |
362 (in isoform 3) | Phosphorylation | - | 37.98 | 28348404 | |
363 | O-linked_Glycosylation | YPGDVDRSSSAGGQG CCCCCCCCCCCCCCC | 24.96 | OGP | |
363 | Phosphorylation | YPGDVDRSSSAGGQG CCCCCCCCCCCCCCC | 24.96 | 21945579 | |
363 (in isoform 3) | Phosphorylation | - | 24.96 | 25262027 | |
364 | Phosphorylation | PGDVDRSSSAGGQGS CCCCCCCCCCCCCCC | 25.71 | 21945579 | |
365 | Phosphorylation | GDVDRSSSAGGQGSY CCCCCCCCCCCCCCE | 31.98 | 21945579 | |
366 (in isoform 3) | Phosphorylation | - | 28.25 | 25262027 | |
371 | O-linked_Glycosylation | SSAGGQGSYVPLLRD CCCCCCCCEEEEECC | 18.31 | 9543037 | |
371 | Phosphorylation | SSAGGQGSYVPLLRD CCCCCCCCEEEEECC | 18.31 | 21945579 | |
372 | Phosphorylation | SAGGQGSYVPLLRDT CCCCCCCEEEEECCC | 16.95 | 21945579 | |
379 | Phosphorylation | YVPLLRDTDSSVASE EEEEECCCCCHHHHH | 31.20 | 21406692 | |
381 | Phosphorylation | PLLRDTDSSVASEVR EEECCCCCHHHHHHH | 28.89 | 21406692 | |
382 | Phosphorylation | LLRDTDSSVASEVRS EECCCCCHHHHHHHC | 25.22 | 21406692 | |
385 | Phosphorylation | DTDSSVASEVRSGYR CCCCHHHHHHHCCCE | 34.17 | 25849741 | |
387 | Phosphorylation | DSSVASEVRSGYRIQ CCHHHHHHHCCCEEE | 5.67 | - | |
388 | Phosphorylation | SSVASEVRSGYRIQA CHHHHHHHCCCEEEE | 21.95 | - | |
389 | Phosphorylation | SVASEVRSGYRIQAS HHHHHHHCCCEEEEE | 45.40 | 25849741 | |
390 | Ubiquitination | VASEVRSGYRIQASQ HHHHHHCCCEEEEEC | 12.74 | 23000965 | |
390 | Ubiquitination | VASEVRSGYRIQASQ HHHHHHCCCEEEEEC | 12.74 | 21890473 | |
390 | Ubiquitination | VASEVRSGYRIQASQ HHHHHHCCCEEEEEC | 12.74 | 21890473 | |
391 | Phosphorylation | ASEVRSGYRIQASQQ HHHHHCCCEEEEECC | 13.04 | 21945579 | |
391 | Ubiquitination | ASEVRSGYRIQASQQ HHHHHCCCEEEEECC | 13.04 | 23000965 | |
391 (in isoform 3) | Ubiquitination | - | 13.04 | 21890473 | |
396 | Phosphorylation | SGYRIQASQQDDSMR CCCEEEEECCCCHHH | 16.40 | 21945579 | |
401 | Phosphorylation | QASQQDDSMRVLYYM EEECCCCHHHHHHHH | 19.44 | 21945579 | |
406 | Phosphorylation | DDSMRVLYYMEKELA CCHHHHHHHHHHHHH | 9.63 | 25159151 | |
407 | Phosphorylation | DSMRVLYYMEKELAN CHHHHHHHHHHHHHC | 8.47 | 28102081 | |
409 | Ubiquitination | MRVLYYMEKELANFD HHHHHHHHHHHHCCC | 27.53 | 23000965 | |
410 | Ubiquitination | RVLYYMEKELANFDP HHHHHHHHHHHCCCC | 41.31 | 23000965 | |
410 (in isoform 1) | Ubiquitination | - | 41.31 | 21890473 | |
413 | Phosphorylation | YYMEKELANFDPSRP HHHHHHHHCCCCCCC | 18.74 | 32645325 | |
417 | Phosphorylation | KELANFDPSRPGPPS HHHHCCCCCCCCCCC | 28.27 | - | |
418 | O-linked_Glycosylation | ELANFDPSRPGPPSG HHHCCCCCCCCCCCC | 53.61 | 317667069 | |
418 | Phosphorylation | ELANFDPSRPGPPSG HHHCCCCCCCCCCCC | 53.61 | 23312004 | |
424 | O-linked_Glycosylation | PSRPGPPSGRVERAM CCCCCCCCCHHHHHH | 42.22 | 54904091 | |
424 | Phosphorylation | PSRPGPPSGRVERAM CCCCCCCCCHHHHHH | 42.22 | 25849741 | |
432 | O-linked_Glycosylation | GRVERAMSEVTSLHE CHHHHHHHHHHHHCC | 28.12 | 20068231 | |
432 | Phosphorylation | GRVERAMSEVTSLHE CHHHHHHHHHHHHCC | 28.12 | 23401153 | |
435 | O-linked_Glycosylation | ERAMSEVTSLHEDDW HHHHHHHHHHCCCCC | 22.86 | 55821261 | |
435 | Phosphorylation | ERAMSEVTSLHEDDW HHHHHHHHHHCCCCC | 22.86 | 30266825 | |
436 | O-linked_Glycosylation | RAMSEVTSLHEDDWR HHHHHHHHHCCCCCC | 32.67 | 9543097 | |
436 | Phosphorylation | RAMSEVTSLHEDDWR HHHHHHHHHCCCCCC | 32.67 | 30266825 | |
444 | O-linked_Glycosylation | LHEDDWRSRPSRGPA HCCCCCCCCCCCCCC | 44.27 | 55821461 | |
445 | Phosphorylation | HEDDWRSRPSRGPAL CCCCCCCCCCCCCCC | 25.33 | - | |
447 | O-linked_Glycosylation | DDWRSRPSRGPALTP CCCCCCCCCCCCCCC | 49.08 | 55821467 | |
447 | Phosphorylation | DDWRSRPSRGPALTP CCCCCCCCCCCCCCC | 49.08 | - | |
452 | Ubiquitination | RPSRGPALTPIRDEE CCCCCCCCCCCCCCC | 7.05 | - | |
453 | O-linked_Glycosylation | PSRGPALTPIRDEEW CCCCCCCCCCCCCCC | 20.83 | 9543109 | |
453 | Phosphorylation | PSRGPALTPIRDEEW CCCCCCCCCCCCCCC | 20.83 | 23927012 | |
464 | O-linked_Glycosylation | DEEWGGHSPRSPRGW CCCCCCCCCCCCCCC | 25.86 | 19651622 | |
464 | Phosphorylation | DEEWGGHSPRSPRGW CCCCCCCCCCCCCCC | 25.86 | 23927012 | |
467 | Phosphorylation | WGGHSPRSPRGWDQE CCCCCCCCCCCCCCC | 23.49 | 21955146 | |
474 | Phosphorylation | SPRGWDQEPAREQAG CCCCCCCCHHHHHCC | 38.15 | - | |
482 | Phosphorylation | PAREQAGGGWRARRP HHHHHCCCCHHCCCC | 35.19 | - | |
491 | Ubiquitination | WRARRPRARSVDALD HHCCCCCCCCCCCHH | 15.69 | 32015554 | |
493 | Phosphorylation | ARRPRARSVDALDDL CCCCCCCCCCCHHHC | 24.30 | 19664994 | |
495 | Phosphorylation | RPRARSVDALDDLTP CCCCCCCCCHHHCCC | 42.53 | - | |
500 | Ubiquitination | SVDALDDLTPPSTAE CCCCHHHCCCCCCCC | 8.48 | 23503661 | |
501 | Phosphorylation | VDALDDLTPPSTAES CCCHHHCCCCCCCCC | 39.90 | 19664994 | |
504 | Phosphorylation | LDDLTPPSTAESGSR HHHCCCCCCCCCCCC | 41.26 | 23401153 | |
505 | O-linked_Glycosylation | DDLTPPSTAESGSRS HHCCCCCCCCCCCCC | 39.97 | OGP | |
505 | Phosphorylation | DDLTPPSTAESGSRS HHCCCCCCCCCCCCC | 39.97 | 30266825 | |
508 | Phosphorylation | TPPSTAESGSRSPTS CCCCCCCCCCCCCCC | 39.34 | 30266825 | |
509 | Phosphorylation | PPSTAESGSRSPTSN CCCCCCCCCCCCCCC | 20.70 | - | |
510 | Phosphorylation | PSTAESGSRSPTSNG CCCCCCCCCCCCCCC | 38.57 | 30266825 | |
511 | Phosphorylation | STAESGSRSPTSNGG CCCCCCCCCCCCCCC | 50.62 | - | |
512 | Phosphorylation | TAESGSRSPTSNGGR CCCCCCCCCCCCCCC | 33.94 | 30266825 | |
514 | Phosphorylation | ESGSRSPTSNGGRSR CCCCCCCCCCCCCCC | 35.75 | 30266825 | |
515 | Phosphorylation | SGSRSPTSNGGRSRA CCCCCCCCCCCCCCC | 36.54 | 30266825 | |
516 | Phosphorylation | GSRSPTSNGGRSRAY CCCCCCCCCCCCCCC | 60.46 | - | |
520 | Phosphorylation | PTSNGGRSRAYMPPR CCCCCCCCCCCCCCC | 25.25 | 23403867 | |
521 | Phosphorylation | TSNGGRSRAYMPPRS CCCCCCCCCCCCCCC | 28.51 | - | |
523 | Phosphorylation | NGGRSRAYMPPRSRS CCCCCCCCCCCCCCC | 14.72 | 27259358 | |
528 | Phosphorylation | RAYMPPRSRSRDDLY CCCCCCCCCCCCCCC | 40.14 | 23401153 | |
530 | Phosphorylation | YMPPRSRSRDDLYDQ CCCCCCCCCCCCCCC | 41.11 | 23927012 | |
532 | Phosphorylation | PPRSRSRDDLYDQDD CCCCCCCCCCCCCCC | 52.06 | 17389395 | |
535 | Phosphorylation | SRSRDDLYDQDDSRD CCCCCCCCCCCCCCC | 20.67 | 27273156 | |
539 | Ubiquitination | DDLYDQDDSRDFPRS CCCCCCCCCCCCCHH | 39.68 | 23503661 | |
540 | Phosphorylation | DLYDQDDSRDFPRSR CCCCCCCCCCCCHHC | 41.88 | 23927012 | |
540 | Ubiquitination | DLYDQDDSRDFPRSR CCCCCCCCCCCCHHC | 41.88 | 23503661 | |
546 | O-linked_Glycosylation | DSRDFPRSRDPHYDD CCCCCCHHCCCCHHC | 41.07 | 46243171 | |
546 | Phosphorylation | DSRDFPRSRDPHYDD CCCCCCHHCCCCHHC | 41.07 | 21945579 | |
550 | Phosphorylation | FPRSRDPHYDDFRSR CCHHCCCCHHCHHCC | 42.83 | 17016520 | |
550 (in isoform 2) | Ubiquitination | - | 42.83 | - | |
551 | Phosphorylation | PRSRDPHYDDFRSRE CHHCCCCHHCHHCCC | 23.69 | 21945579 | |
556 | Phosphorylation | PHYDDFRSRERPPAD CCHHCHHCCCCCCCC | 38.19 | 21945579 | |
559 | Ubiquitination | DDFRSRERPPADPRS HCHHCCCCCCCCCCC | 41.20 | 23503661 | |
562 | Phosphorylation | RSRERPPADPRSHHH HCCCCCCCCCCCCCC | 41.97 | - | |
567 | Phosphorylation | PPADPRSHHHRTRDP CCCCCCCCCCCCCCC | 23.27 | 17389395 | |
579 | Phosphorylation | RDPRDNGSRSGDLPY CCCCCCCCCCCCCCC | 29.54 | 23401153 | |
581 | Phosphorylation | PRDNGSRSGDLPYDG CCCCCCCCCCCCCCC | 38.05 | 19664994 | |
586 | Phosphorylation | SRSGDLPYDGRLLEE CCCCCCCCCCHHHHH | 38.02 | 27273156 | |
588 | Ubiquitination | SGDLPYDGRLLEEAV CCCCCCCCHHHHHHH | 19.11 | 23503661 | |
589 | Ubiquitination | GDLPYDGRLLEEAVR CCCCCCCHHHHHHHH | 32.95 | 23503661 | |
596 | Phosphorylation | RLLEEAVRKKGSEER HHHHHHHHHCCCHHH | 41.85 | - | |
597 | Phosphorylation | LLEEAVRKKGSEERR HHHHHHHHCCCHHHC | 55.69 | - | |
604 | Phosphorylation | KKGSEERRRPHKEEE HCCCHHHCCCCHHHH | 60.81 | - | |
607 | Ubiquitination | SEERRRPHKEEEEEA CHHHCCCCHHHHHHH | 48.63 | 23503661 | |
608 | Ubiquitination | EERRRPHKEEEEEAY HHHCCCCHHHHHHHC | 70.29 | 23503661 | |
615 | Phosphorylation | KEEEEEAYYPPAPPP HHHHHHHCCCCCCCC | 21.56 | 21945579 | |
616 | Phosphorylation | EEEEEAYYPPAPPPY HHHHHHCCCCCCCCC | 15.13 | 21945579 | |
623 | Phosphorylation | YPPAPPPYSETDSQA CCCCCCCCCCCCCHH | 25.55 | 26657352 | |
624 | Phosphorylation | PPAPPPYSETDSQAS CCCCCCCCCCCCHHH | 39.53 | 21945579 | |
626 | Phosphorylation | APPPYSETDSQASRE CCCCCCCCCCHHHHH | 34.70 | 21945579 | |
627 | Phosphorylation | PPPYSETDSQASRER CCCCCCCCCHHHHHH | 34.40 | - | |
628 | Phosphorylation | PPYSETDSQASRERR CCCCCCCCHHHHHHH | 34.76 | 21945579 | |
631 | Phosphorylation | SETDSQASRERRLKK CCCCCHHHHHHHHHH | 27.34 | 21945579 | |
638 | Ubiquitination | SRERRLKKNLALSRE HHHHHHHHHHCCCHH | 62.88 | - | |
643 | Phosphorylation | LKKNLALSRESLVV- HHHHHCCCHHHCCC- | 28.52 | 26846344 | |
646 | Phosphorylation | NLALSRESLVV---- HHCCCHHHCCC---- | 25.92 | 26846344 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LSR_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LSR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LSR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RARG_HUMAN | RARG | physical | 21988832 | |
MAPK5_HUMAN | MAPKAPK5 | physical | 21988832 | |
STON2_HUMAN | STON2 | physical | 28514442 | |
EPS15_HUMAN | EPS15 | physical | 28514442 | |
RBP1_HUMAN | RALBP1 | physical | 28514442 | |
EP15R_HUMAN | EPS15L1 | physical | 28514442 | |
SMAD5_HUMAN | SMAD5 | physical | 28514442 | |
REPS1_HUMAN | REPS1 | physical | 28514442 | |
ITSN1_HUMAN | ITSN1 | physical | 28514442 | |
AP1B1_HUMAN | AP1B1 | physical | 28514442 | |
AP2A2_HUMAN | AP2A2 | physical | 28514442 | |
VPS45_HUMAN | VPS45 | physical | 28514442 | |
AP2A1_HUMAN | AP2A1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-643, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-643 AND SER-646, ANDMASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528 AND SER-530, ANDMASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-646, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-372 AND TYR-406, ANDMASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-551 AND TYR-586, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-309; TYR-328; TYR-406;TYR-535; TYR-551; TYR-586 AND TYR-615, AND MASS SPECTROMETRY. |